Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

• Status: Completed
• Trial end date: 2014-09-01

Summary

This trial is randomized, placebo-controlled, double blind, double dummy, multi-centre trial.

• Screening period (4 week)

• Double blind treatment period (16 weeks)

• Phase: Phase 2

Details

• Lead Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
• Treatments: Probucol